Hugo Miguel Vicente Miranda (2719-3B78-B060)

Curriculum Vitae

Hugo Miguel Vicente Miranda

In September 2018, Hugo Vicente Miranda became a Principal Investigator and Affiliated Assistant Professor at Universidade NOVA de Lisboa, NOVA Medical School, in Portugal. Protein misfolding is a central problem in biology and is accepted as the major underpinning of neurodegenerative diseases such as Parkinson's, Alzheimer's and Huntington's disease. Vicente Miranda research has been focused on identifying strategies that prevent or halt the neurotoxicity induced by misfolded proteins, in particular of alpha-synuclein (aSyn). There is a strong association between diabetes and neurodegenerative diseases. Notably, young type-II diabetes patients have 380% higher risk of developing PD. Moreover, diabetes elicits faster motor decline progression, cognitive decline and lower binding of dopamine to its transporter in the striatum. During his PhD and Post-doc training, Vicente Miranda established that glycation is an underlying link between diabetes and Parkinson's disease. He identified aSyn as a target of MGO glycation, triggering its pathology. At the Lab of Professor Tiago F Outeiro, a world-class leader in PD, he also discovered the mechanism underlying the potential of Sirtuin 2 inhibition as a therapeutic strategy for PD. In his first independent project, he identified that aSyn post-translational modifications are biomarkers of PD with high diagnostic potential. In 2018, Dr. Vicente Miranda established his own group, the Dysmetabolism in Brain Diseases (DysBrainD) laboratory at NOVA Medical School, Lisbon, Portugal. The major aim of DysBrainD is to unveil novel molecular targets, whose modulation, based in the repositioning of approved drugs, presents therapeutic utility. DysBrainD aims to validate their usage in models of the disease and perform pre-clinical validation research in cohorts of PD and diabetic individuals. Recently, his group determined the protective potential of Hsp27 in Parkinson's disease. He and his team also reported that Brain glycation triggers Parkinson's disease-like behaviour and neuropathological features, by exacerbating glutamatergic signaling and by altering oxidative phosphorylation components. Dr. Vicente Miranda has published 29 papers in specialised journals (several manuscripts in top journals such as Brain, PLoS Biology, Nature Neuroscience), was awarded several grants and prizes, was invited for oral talks in several congresses, and participates in the peer review of papers and projects. Dr. Vicente Miranda won the Great Prize from Portuguese Diabetes Society in 2021, and is currently elected member of NOVA Medical School Council.

Ler resumo completo ↓

Identificação

Identificação pessoal

Nome completo: Hugo Miguel Vicente Miranda
Data de nascimento: 1982/12/31
Género: Masculino

Nomes de citação

Vicente Miranda, Hugo

Identificadores de autor

Ciência ID: 2719-3B78-B060
ORCID iD: 0000-0001-8065-9259
Google Scholar ID: 26igPEoAAAAJ
Researcher Id: I-3525-2013
Scopus Author Id: 57193826021

Endereços de correio eletrónico

hmvmiranda@nms.unl.pt (Profissional)

Telefones

Telefone

(+351) 218803127 (Profissional)

Moradas

NOVA Medical School / Faculdade de Ciências Médicas, Universidade Nova de Lisboa. Rua Câmara Pestana nº 6 | Edifício CEDOC II, 1150-082, Lisboa, Lisboa, Portugal (Profissional)

Websites

https://nms.unl.pt/pt-pt/investigacao/grupos-de-investigacao/detalhe/n/dysbraind-dismetabolismo-em-doencas-do-cerebro (Profissional)

Domínios de atuação

Ciências Médicas e da Saúde - Medicina Básica - Neurociências
Ciências Naturais - Ciências Biológicas - Bioquímica

Idiomas

Idioma	Conversação	Leitura	Escrita	Compreensão	Peer-review
Português (Idioma materno)
Inglês	Utilizador proficiente (C1)	Utilizador proficiente (C1)	Utilizador proficiente (C1)	Utilizador proficiente (C1)	Utilizador proficiente (C1)

Formação

	Grau	Classificação
2016/09/01 - 2019/01/31 Concluído	Neurosciences - Targeting the glycation defenses as a protective strategy for Parkinson’s disease (Pós-doutoramento) Instituto de Medicina Molecular, Portugal Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal
2018 - 2018 Concluído	Grant Writing Intensive - Magdalena Bak-Maier (Outros) Especialização em Grant Writing Universidade Nova de Lisboa, Portugal Make Time Count Ltd, Reino Unido
2017 - 2017 Concluído	Supervision skills development course (Outros) Especialização em Supervisão Universidade Nova de Lisboa, Portugal
2014/01/01 - 2016/08/31 Concluído	Neurosciences - Part 2: Modulation of alpha-synuclein aggregation and toxicity: protective strategies for Parkinson’s disease (Pós-doutoramento) Instituto de Medicina Molecular, Portugal
2014 - 2014 Concluído	Science Communication workshop - Malcolm Love (Outros) Especialização em Science Communication Blackwell's University of the West of England, Reino Unido
2013/02 - 2013/12 Concluído	Identification of factors that influence a-synuclein oligomerization in cell culture and in vivo (Pós-doutoramento) Instituto de Medicina Molecular, Portugal
2010/02/01 - 2013/01/31 Concluído	Neurosciences - Part 1: Modulation of alpha-synuclein aggregation and toxicity: protective strategies for Parkinson’s disease (Pós-doutoramento) Instituto de Medicina Molecular, Portugal
2010/02 - 2013/01 Concluído	Neurosciences: Modulation of alpha-synuclein aggregation and toxicity: protective strategies for Parkinson’s disease (Pós-doutoramento) Instituto de Medicina Molecular, Portugal
2013 - 2013 Concluído	Grant Writing Workshop - Judith A. Swan (Outros) Especialização em Grant Writing Princeton University, Estados Unidos Instituto de Medicina Molecular, Portugal
2010/01/20 Concluído	Biochemistry (Doutoramento) Especialização em Specialty: Biochemical Regulation Universidade de Lisboa, Portugal "Protein Glycation and Methylglyoxal Metabolism in Parkinson´s Disease" (TESE/DISSERTAÇÃO)	summa cum laude
2010 - 2010 Concluído	Quantitative Light Microscopy in Living Cells by Harvard Medical School Portugal Program (Outros) Especialização em Microscopy Harvard Medical School, Estados Unidos Instituto de Medicina Molecular, Portugal
2008 - 2008 Concluído	Advanced training in FTMS-ICR (Outros) Especialização em Mass Spectrometry Bruker Daltonik GmbH, Alemanha Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
2005/07 Concluído	Bioquímica (Licenciatura) Universidade de Lisboa Faculdade de Ciências, Portugal "Methylglyoxal metabolism and glycation in Saccharomyces cerevisiae Metabolismo do metilglioxal e glicação em Saccharomyces cerevisiae" (TESE/DISSERTAÇÃO)	17
2005 - 2005 Concluído	Identification of proteins using mass spectrometry data – practical course (Outros) Especialização em Mass spectrometry Thermo Fisher Scientific Inc Darmstadt, Alemanha Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal

Percurso profissional

Docência no Ensino Superior

	Categoria Profissional Instituição de acolhimento	Empregador
2019/09/01 - Atual	Professor Auxiliar Convidado (Docente Universitário)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Cargos e Funções

	Categoria Profissional Instituição de acolhimento	Empregador
2023/01 - Atual	Vice-Coordinator of Cardiovascular, Renal and Metabolism Research Area	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2018/08 - Atual	Scientific Advisor	Dart-Diagnostics, Portugal

2017 - Atual	Review Editor - Area of Neurodegeneration	Frontiers - Academic Journals and Research Community, Suiça
	Frontiers - Academic Journals and Research Community, Suiça
2020/12 - 2023/12	FACULTY COUNCIL - Elected member	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Outros

	Categoria Profissional Instituição de acolhimento	Empregador
2021 - Atual	Review Editor - Metabolic Physiology	Frontiers - Academic Journals and Research Community, Suiça
	Frontiers - Academic Journals and Research Community, Suiça
2021 - Atual	Sustainability Council	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2018/09/01 - Atual	Principal Investigator - Group Leader	Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal

2015/01/01 - 2019/01/31	Post-doctoral researcher (funded by FCT)	Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal

2014/01/01 - 2019/01/31	Post-doctoral Researcher (funded by FCT)	Instituto de Medicina Molecular, Portugal

2013/02/01 - 2013/12/31	Post-doctoral Researcher (Funded by Seventh Framework Programme (FP7) – Medelian Forms of Parkinson’s Disease	Instituto de Medicina Molecular, Portugal

2010/02/01 - 2013/01/31	Post-doc researcher (funded by FCT)	Instituto de Medicina Molecular, Portugal

2005/01/01 - 2010/01/20	PhD Researcher (funded by FCT)	Universidade de Lisboa Departamento de Química e Bioquímica, Portugal

Projetos

Bolsa

	Designação	Financiadores
2022 - Atual	Role of a-synuclein in synucleinopathy Marohn Stiftung Investigador Universitätsklinikum Erlangen, Alemanha	IZKF Em curso
2019/09/16 - 2024/02/29	Unveiling insulin degrading enzyme as a therapeutic target for Parkinson’s disease (Supervisor of PhD Grant) SFRH/BD/144743/2019 Orientador Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal	Fundação para a Ciência e a Tecnologia Em curso
2018/03/01 - 2022/02/28	Underlying role of glycation in the pathogenesis of Parkinson's disease (Supervisor of PhD Grant) PD/BD/136863/2018 Orientador Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal	Fundação para a Ciência e a Tecnologia Em curso
2021 - 2021	EMBO short term fellowship - Potential of anti-diabetics to ameliorate aSyn pathology - EUR 9.090,00 STF 8707 Orientador University of Leicester, Reino Unido Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal	Gesellschaft zur Förderung der Lebenswissenschaften Heidelberg GmbH Em curso

Projeto

	Designação	Financiadores
2021 - Atual	IDE Biomarker Potential - EUR 5.000,00 SPD - GIFT 2021 Investigador responsável Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal	Sociedade Portuguesa de Diabetologia Em curso
2023/04 - 2027/03	Evaluating an Insulin-degrading Enzyme as a Novel Therapeutic Target for Parkinson's Disease - EUR 217.000,00 and EUR 200.000,00 of possible extension MJFF-021400 Investigador responsável iNOVA4Health, Portugal	Michael J Fox Foundation for Parkinson's Research Em curso
2022/11 - 2024/12	In the Crossroad between metabolic and neurodegenerative diseases - Requested EUR 21.500,00 - Already funded EUR 6.000,00 N/A Investigador responsável Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal	iNOVA4Health Em curso
2023/06 - 2024/05	Modulation of carotid body activity as a therapeutic strategy in the prevention of cognitive decline [EUR 5.000,00] Bolsa José Luís Medina Co-Investigador Responsável (Co-IR) iNOVA4Health, Portugal	Sociedade Portuguesa de Diabetologia Em curso
2021 - 2023	Preventing the development of Parkinson's disease in type-2 diabetes patients - EUR 20.000,00 BigPrize 2021 Investigador responsável Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal	Sociedade Portuguesa de Diabetologia Em curso
2018/01 - 2020/12	Sugar stress in the brain: the missing link between aging, diabetes and Parkinson's disease. [EUR 70.000,00] PI/Coordinator Multi/04462 Investigador responsável iNOVA4Health, Portugal	iNOVA4Health Concluído
2016/06/01 - 2020/02/29	Targeting the glycation defenses as a protective strategy for Parkinson's Disease [EUR 199.961,00] PI PTDC/NEU-OSD/5644/2014 Investigador responsável Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal	Fundação para a Ciência e a Tecnologia Em curso
2018/03/01 - 2019/12/31	Sugar stress in the brain [EUR 5000,00] PI SPD2018 Charneco da Costa Investigador responsável Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal	Sociedade Portuguesa de Diabetologia Em curso
2016/05/01 - 2019/10/31	Alzheimer3D: Trifunctional Conjugates for the Selective Drug Delivery in Alzheimer's Disease [EUR 198.364,00] PTDC/QEQ-MED/5512/2014 Investigador Universidade de Lisboa Faculdade de Medicina Veterinária, Portugal	Fundação para a Ciência e a Tecnologia Em curso
2016/09/01 - 2019/01/31	Targeting the glycation defenses as a protective strategy for Parkinson's disease. [EUR 118.000,00] Post-Doc Awardee SFRH/BPD/109347/2015 Bolseiro de Pós-Doutoramento Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal Instituto de Medicina Molecular, Portugal	Fundação para a Ciência e a Tecnologia Em curso
2016/09/01 - 2017/12	Targeting the glycation defenses as a protective strategy for Parkinson's Disease PTDC/NEU-OSD/5644/2014 Orientador Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal	Fundação para a Ciência e a Tecnologia Em curso
2010/02 - 2016/12	Modulation of alpha-synuclein aggregation and toxicity: protective strategies for Parkinson's disease. [EUR 115.000,00] - Post-doc position Awardee SFRH / BPD / 64701 / 2009 Bolseiro de Pós-Doutoramento Instituto de Medicina Molecular, Portugal	Foundation for Science and Tecnology Concluído
2011 - 2015	Molecular determinants of microglial activation and neuronal dysfunction in in vivo models of Parkinson's disease. [EUR 115.664,00] PTDC/SAU-ORG/114083/2009 Investigador Instituto de Medicina Molecular, Portugal	Fundação para a Ciência e a Tecnologia Concluído
2013/06/01 - 2014/05/31	Alpha-synuclein as a blood biomarker for Parkinson's disease info:eu-repo/grantAgreement/FCT/3599-PPCDT/126579/PT Orientador	Fundação para a Ciência e a Tecnologia Concluído
2013 - 2014	Alpha-synuclein as a blood biomarker for Parkinson's Disease [EUR 50.000,00] PI EXPL/NEU-OSD/0606/2012 Investigador responsável Instituto de Medicina Molecular, Portugal	Fundação para a Ciência e a Tecnologia Concluído
2012 - 2013	Identification of factors that influence alpha-synuclein oligomerization in cell culture and in vivo. [EUR 21.500,00] - Researcher MEFOPA Bolseiro de Pós-Doutoramento Instituto de Medicina Molecular, Portugal	European Commission Seventh Framework Programme for Research and Technological Development Concluído
2009 - 2013	Neurasync. Seventh Framework Programme FP7-PEOPLE-ITN-2008 Investigador Instituto de Medicina Molecular, Portugal	European Commission Seventh Framework Programme for Research and Technological Development Concluído
2010/01/01 - 2012	Radiolabeled Benzazole Derivatives for In Vivo Imaging of Amyloid Aggregation. [EUR 197.596,00] - Researcher info:eu-repo/grantAgreement/FCT/3599-PPCDT/102049/PT Investigador Universidade de Lisboa Instituto Superior Técnico, Portugal	Fundação para a Ciência e a Tecnologia Concluído
2006/01 - 2010/01	Protein Glycation and Methylglyoxal Metabolism in Parkinson's Disease. [EUR 55.000,00] - PhD position Awardee SFRH/BD/23035/ 2005 Bolseiro de Doutoramento Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal	Foundation for Science and Tecnology Fundação para a Ciência e a Tecnologia Concluído
2006 - 2010	Toward an understanding of protein glycation in Parkinson¿s disease. [EUR 76.200,00] - Researcher PTDC/QUI/73430/2006 Investigador Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal Instituto Superior de Ciências da Saúde Egas Moniz, Portugal	Fundação para a Ciência e a Tecnologia Concluído

Outro

	Designação	Financiadores
2012/09/01 - 2013/10	Modulation of a-synuclein aggregation and toxicity MSc Thesis Orientador	Concluído

Produções

Publicações

Artigo em conferência	Abecasis, JPR; Ferreira, AEN; Vicente Miranda, Hugo; Gomes, Ricardo Anjos; Sousa Silva, Marta; Cordeiro, Carlos; Ponces-Freire, Ana. "Parameter estimation in multi-enzyme systems using evolutionary algorithms". Trabalho apresentado em BKDB2005 – Bioinformatics: Knowledge Discovery in Biology, 2005. Publicado • 10.13140/RG.2.1.1468.8802
Artigo em revista	Vicente Miranda, Hugo. "TOTAL NUMBER OF ARTICLES: 33, Accumulated IF: 179 , Average IF: 6 \| SINCE 2017: 14 Published Papers with Average IF 7.2 (5 papers with IF >9), 8 as Senior author \| CITATIONS: >2250 (Google Scholar) \| >1560 (Clarivate) \| >1610 (SCOPUS) \| h-index 19 (Clarivate & SCOPUS)". (2023): Chegão, Ana; Vicente Miranda, Hugo. "Unveiling new secrets in Parkinson's disease: The glycatome - CORRESPONDING AUTHOR". Behavioural Brain Research 442 (2023): 114309. http://dx.doi.org/10.1016/j.bbr.2023.114309 \| IF=3.65 (2021). Acesso aberto • Publicado • 10.1016/j.bbr.2023.114309 Chegão A; Fernandes Gomes B; Outeiro TF; Vicente Miranda, Hugo. "Metformin prevents the deleterious effects of glycation in cellular models of Parkinson's disease. (Under Preparation)". N/A N/A (2023): N/A-N/A. Fonseca Gomes, J; Rodrigues, Tiago M; Vaz, Sandra H; Ramalho, R M; Vicente Miranda, Hugo; Tanqueiro, S; Miranda-Lourenço, C; et al. "A Small TAT-TrkB Peptide Prevents BDNF Receptor Cleavage and Restores Synaptic Physiology in Alzheimer's Disease (Submitted)". (2023): Acesso aberto • Submetido Chegão, Ana; Alexandre, Bruno M; Matthiesen, Rune; Lopes, Luísa V.; Anjos-Gomes, Ricardo; GOMES-ALVES, Patrícia; Coelho, Joana Esteves ; Outeiro, Tiago Fleming; Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. "aSyn overexpression impairs oxidative phosphorylation, endocytosis, and synaptic vesicle dynamics in the midbrain (Under Preparation)". npj Parkinson's Disease (2023): Submetido Chegão, Ana; Guarda, Mariana; Alexandre, Bruno M.; Shvachiy, Liana; Temido-Ferreira, Mariana; Marques-Morgado, Inês; Fernandes Gomes, Bárbara; et al. Autor correspondente: Vicente Miranda, Hugo. "Glycation modulates glutamatergic signaling and exacerbates Parkinsons disease-like phenotypes. CORRESPONDING AUTHOR". npj Parkinson's Disease 8 1 (2022): http://dx.doi.org/10.1038/s41531-022-00314-x \| IF = 9.3 (2021) \| Citations: 5 (Google Scholar) 4 (Clarivate) 4 (SCOPUS) \| TOP 6% Q1 Medicine (Neurology - clinical). Publicado • 10.1038/s41531-022-00314-x Capucho, Adriana M.; Chegão, Ana; Martins, Fátima O.; Vicente Miranda, Hugo; Conde, Sílvia V.. "Dysmetabolism and Neurodegeneration: Trick or Treat?". Nutrients 14 7 (2022): 1425. http://dx.doi.org/10.3390/nu14071425 - IF = 6.7 (2021) \| Citations: 6 (Google Scholar) 5 (Clarivate) 5 (SCOPUS) \| TOP 6% Q1 Agricultural and Biological Sciences (Food Science) (SCIMago). Publicado • 10.3390/nu14071425 Vicente Miranda, Hugo. "Can We Prevent the Development of Parkinson’s Disease in Type-2 Diabetes Mellitus Patients?". Revista Portuguesa de Diabetes 16 4 (2021): 162-163. http://www.revportdiabetes.com/wp-content/uploads/2022/01/RPD_DEZ_2021_Editorial_Hugo_Vicente_Miranda_162-163.pdf. Acesso aberto • Publicado Sousa, Luís; Guarda, Mariana; Meneses, Maria João; Macedo, M Paula; Vicente Miranda, Hugo. "Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases CORRESPONDING AUTHOR". The Journal of Pathology 255 4 (2021): 346-361. http://dx.doi.org/10.1002/path.5777 \| IF 2021: 9.883 \| Citations: 23 (Google Scholar) 19 (Clarivate) 21 (SCOPUS) \| 6th Best, TOP 3% in Medicine - Pathology and Forensic Medicine (SCImago-2021). 10.1002/path.5777 Ana Chegão; Mariana Guarda; Alexandre BM; Shvachiy, Liana; Mariana Temido-Ferreira; Inês Marques-Morgado; Bárbara Fernandes Gomes; et al. Autor correspondente: Vicente Miranda, Hugo. "Exacerbation of Parkinson’s disease-like phenotypes by glycation involves glutamatergic signaling". BioRxiv (2021): https://doi.org/10.1101/2021.08.24.457507. Publicado Belo, Rita F.; Martins, Margarida L. F.; Shvachiy, Liana; Costa-Coelho, Tiago; de Almeida-Borlido, Carolina; Fonseca-Gomes, João; Neves, Vera; et al. "The Neuroprotective Action of Amidated-Kyotorphin on Amyloid ß Peptide-Induced Alzheimer’s Disease Pathophysiology". Frontiers in Pharmacology 11 (2020): http://dx.doi.org/10.3389/fphar.2020.00985 \| IF 5.811, IF (5 years) 5.553 \| Citations: 8 (Google Scholar) 6 (Clarivate) 6 (SCOPUS) \| Q1 Pharmacology (SCIMago). Acesso aberto • 10.3389/fphar.2020.00985 Vicente Miranda, Hugo; Chegão, Ana; Oliveira, Márcia S.; Fernandes Gomes, Bárbara; Enguita, Francisco J.; Outeiro, Tiago Fleming. "Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein CORRESPONDING AUTHOR". The FASEB Journal* Epub ahead of (2020): print. http://dx.doi.org/10.1096/fj.201902936r \| IF 2020: 5.2 \| Citations: 17 (Google Scholar) 14 (Clarivate) 13 (SCOPUS) \| TOP 6% in Medicine (SCImago-2020) \| Corresponding author. Acesso aberto • Publicado • 10.1096/fj.201902936r Vicente Miranda, Hugo; Ana Chegão; Bárbara Fernandes Gomes; Francisco J. Enguita; Tiago Fleming Outeiro. "Hsp27 reduces glycation-induced toxicity and aggregation of a-synuclein CORRESPONDING AUTHOR". bioRxiv 2020.03.03 975037 (2020): https://www.biorxiv.org/content/10.1101/2020.03.03.975037v1. Acesso aberto • Publicado Gomes, J. I.; Fonseca Gomes, J.; Vicente Miranda, Hugo; Sebastiao, A. M.; Diogenes, M. J.; Vaz, S. H.. "Astrocytic signaling upon Aß-mediated excitotoxicity". Frontiers in Cellular Neuroscience (2019): https://www.frontiersin.org/10.3389/conf.fncel.2019.01.00023/event_abstract. Publicado Hoffmann, Anna-Carin; Minakaki, Georgia; Menges, Stefanie; Salvi, Rachele; Savitskiy, Sergey; Kazman, Aida; Vicente Miranda, Hugo; et al. "Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose". Scientific Reports 9 1 (2019): http://dx.doi.org/10.1038/s41598-018-35811-8 \| IF=4.1; TOP 5%, \| TOP 5% Q1 Multidisciplinary (SCImago-2018) \| Citations: 105 (Google Scholar) 73 (Clarivate) 74 (SCOPUS). Publicado • 10.1038/s41598-018-35811-8 König, Annekatrin; Vicente Miranda, Hugo; Outeiro, Tiago Fleming. "Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's disease". Journal of Parkinson's disease 8 1 (2018): 33-43. http://dx.doi.org/10.3233/jpd-171285 \| IF 2018: 3.698; last 5-year = 5.121 (ISI) Citations: 43 (Google Scholar) 27 (Clarivate) 32 (SCOPUS) \| Q1 Neurology (clinical) (SCImago-2018). 10.3233/jpd-171285 Vicente Miranda, Hugo; Cássio, Rafaela; Correia-Guedes, Leonor; Gomes, Marcos António; Chegão, Ana; Miranda, Elisa; Soares, Tiago; et al. "Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease. CORRESPONDING AUTHOR". Scientific Reports* 7 1 (2017): http://dx.doi.org/10.1038/s41598-017-14175-5 \| IF 2017: 4.122; last 5-year = 4.609 (ISI) Citations: 78 (Google Scholar); 59 (Clarivate); 58 (SCOPUS) \| TOP 5%, Q1, Multidisciplinary (SCImago-2017). Acesso aberto • Publicado • 10.1038/s41598-017-14175-5 Ferreira, Diana G; Temido-Ferreira, Mariana; Miranda, Hugo Vicente; Batalha, Vânia L; Coelho, Joana E; Szegö, Éva M; Marques-Morgado, Inês; et al. "a-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B.". Nature Neuroscience 20 11 (2017): 1569-1579. http://dx.doi.org/10.1038/nn.4648 \| IF 2017: 19.9; last 5-year = 19.2 (ISI) Citations: 228 (Google Scholar); 160 (Clarivate); 164 (SCOPUS) \| TOP 1%, Second Best - Q1 Neuroscience (SCImago-2016). 10.1038/nn.4648 Vicente Miranda, Hugo; Szego, Éva M.; Oliveira, Luís M. A.; Breda, Carlo; Darendelioglu, Ekrem; de Oliveira, Rita M.; Ferreira, Diana G.; et al. "Glycation potentiates a-synuclein-associated neurodegeneration in synucleinopathies.". Brain 140 5 (2017): 1399-1419. http://dx.doi.org/10.1093/brain/awx056 \| IF 2017: 11; last 5-year = 11.2 (ISI) Citations: 165 (G. Scholar) 116 (Scopus) 111 (Clarivate) TOP 1%, Third Best Journal in Neurology (SCIMago). 10.1093/brain/awx056 de Oliveira, Rita Machado* Co-first; Vicente Miranda, Hugo Co-first; Francelle, Laetitia; Pinho, Raquel; Szegö, Éva M.; Martinho, Renato; Munari, Francesca; et al. "Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease". PLOS Biology* 15 4 (2017): e1002601. http://dx.doi.org/10.1371/journal.pbio.1002601. Publicado • 10.1371/journal.pbio.1002601 de Oliveira, Rita Machado* Co-first; Vicente Miranda, Hugo* Co-first; Francelle, Laetitia; Pinho, Raquel; Szegö, Éva M.; Martinho, Renato; Munari, Francesca; et al. "The mechanism of sirtuin 2 mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease". PLOS Biology 15 3 (2017): e2000374. http://dx.doi.org/10.1371/journal.pbio.2000374 \| IF 2017: 9.2; last 5-year = 10.2 (ISI) Citations: 130 (Google Scholar); 88 (Clarivate); 98 (Scopus) \| TOP 1%, Second Best - Agricultural and Biological Sciences (miscellaneous) (SCIma. Publicado • 10.1371/journal.pbio.2000374 Ferreira, Diana G.; Batalha, Vânia L.; Vicente Miranda, Hugo; Coelho, Joana E.; Gomes, Rui; Gonçalves, Francisco Q.; Real, Joana I.; et al. "Adenosine A2A Receptors Modulate a-Synuclein Aggregation and Toxicity". Cerebral Cortex 27 1 (2017): 718-730. http://dx.doi.org/10.1093/cercor/bhv268 \| IF 2015 - 8.3; last 5-year - 7.9 (ISI) Citations: 78 (Google Scholar); 54 (Clarivate), 53 (Scopus) \| TOP 5%, Fourth Best - Cell and Molecular Neuroscience (SCImago - 2015). Publicado • 10.1093/cercor/bhv268 Goreti Ribeiro Morais []; Elisa Palma; Fernanda Marques; Lurdes Gano; Maria Cristina Oliveira; Antero Abrunhosa; Hugo Vicente Miranda; et al. "Synthesis and Biological Evaluation of Novel 2-Aryl Benzimidazoles as Chemotherapeutic Agents". Journal of Heterocyclic Chemistry (2017): n/a-n/a. http://dx.doi.org/10.1002/jhet.2575 \| IF 2016 0.893; last 5-year 0.866 (ISI) \| Citations: 11 (Google Scholar); 7 (Clarivate); 7 (SCOPUS) \| Q3 Organic Chemistry (SCImago-2016). 10.1002/jhet.2575 Vicente Miranda, Hugo; Gomes, Marcos António; Branco-Santos, Joana; Breda, Carlo; Lázaro, Diana F.; Lopes, Luísa Vaqueiro; Herrera, Federico; Giorgini, Flaviano; Outeiro, Tiago Fleming. "Glycation potentiates neurodegeneration in models of Huntington's disease". Scientific Reports 6 1 (2016): http://dx.doi.org/10.1038/srep36798 \| IF 2016: 4.3; last 5-year = 4.9 (ISI) Citations: 29 (Google Scholar); 21 (Clarivate); 20 (Scopus) \| TOP 5%, Fifth Best - Q1 Multidisciplinary (SCImago-2016). Publicado • 10.1038/srep36798 Outeiro, Tiago Fleming; Vicente Miranda, H. "B7 Glycation potentiates neurodegeneration in models of huntington’s disease". Journal of Neurology, Neurosurgery & Psychiatry 87 Suppl 1 (2016): A11.2-A11. http://dx.doi.org/10.1136/jnnp-2016-314597.38 \| IF (2016): 7.349, IF (last 5-year): 7.160 (ISI) TOP 3% - Q1, #211 in 6670 - Medicine (Scimago-2016). 10.1136/jnnp-2016-314597.38 Vicente Miranda, Hugo; El-Agnaf, Omar M. A.; Outeiro, Tiago Fleming. "Glycation in Parkinson's disease and Alzheimer's disease". Movement Disorders 31 6 (2016): 782-790. http://dx.doi.org/10.1002/mds.26566 \| IF 2016 = 7.1; last 5-year = 6.4 (ISI) \| Citations: 129 (Google Scholar); 88 (Clarivate); 92 (Scopus) \| TOP 5% - Q1 Neurology (clinical) (SCImago-2016). Publicado • 10.1002/mds.26566 Nunes, Patrique; Morais, Goreti Ribeiro; Palma, Elisa; Silva, Francisco; Oliveira, Maria Cristina; Ferreira, Vera F. C.; Mendes, Filipa; et al. "Isostructural Re(i)/99mTc(i) tricarbonyl complexes for cancer theranostics". Organic & Biomolecular Chemistry 13 18 (2015): 5182-5194. http://dx.doi.org/10.1039/c5ob00124b \| IF 2015 = 3.6; last 5-year = 3.4 (ISI) Citations: 18 (Google Scholar); 16 (Clarivate); 17 (Scopus) \| Q1 Biochemistry (SCImago - 2015). Publicado • 10.1039/c5ob00124b Macedo, Diana; Tavares, Lucélia; McDougall, Gordon J.; Vicente Miranda, Hugo; Stewart, Derek; Ferreira, Ricardo B.; Tenreiro, Sandra; Outeiro, Tiago F.; Santos, Cláudia N.. "(Poly)phenols protect from a-synuclein toxicity by reducing oxidative stress and promoting autophagy". Human Molecular Genetics 24 6 (2014): 1717-1732. http://dx.doi.org/10.1093/hmg/ddu585 \| IF 2014 = 6.4; last 5-year = 6.9 (ISI) Citations: 73 (Google Scholar); 58 (Clarivate); 61 (Scopus) \| TOP 5% - Q1 Genetics (SCImago - 2014). Publicado • 10.1093/hmg/ddu585 Vicente Miranda, H.; Gomes, M.; Branco dos Santos, J.; Giorgini, F.; Outeiro, T.. "B08 Glycation Modulates Huntingtin Aggregation And Toxicity". Journal of Neurology, Neurosurgery & Psychiatry 85 Suppl 1 (2014): A11-A11. http://dx.doi.org/10.1136/jnnp-2014-309032.36 \| IF (2014): 6.81, IF (last 5-year): 5.577 (ISI) TOP 3% - Q1, #215 in 6613 - Medicine (Scimago-2015). Publicado • 10.1136/jnnp-2014-309032.36 Vicente Miranda, H; Xiang, Wei; de Oliveira, Rita M.; Simões, Tânia; Pimentel, José; Klucken, Jochen; Penque, Deborah; Outeiro, Tiago F.. "Heat-mediated enrichment of a-synuclein from cells and tissue for assessing post-translational modifications". Journal of Neurochemistry 126 5 (2013): 673-684. http://dx.doi.org/10.1111/jnc.12251 \| IF 2013 - 4.244; last 5-year = 4 (ISI) Citations: 26 (Google Scholar); 15 (Clarivate), 17 (Scopus) \| Q1 Biochemistry (SCImago - 2013). Publicado • 10.1111/jnc.12251 Diogenes, M. J.; Dias, R. B.; Rombo, D. M.; Vicente Miranda, H.; Maiolino, F.; Guerreiro, P.; Nasstrom, T.; et al. "Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation". Journal of Neuroscience 32 34 (2012): 11750-11762. http://dx.doi.org/10.1523/jneurosci.0234-12.2012 \| IF 2012 = 6.9; last 5-year = 7.4 (ISI) Citations: 268 (Google Scholar); 191 (Clarivate); 193 (Scopus) \| Q1, (6.5%) - Neurosciences (miscellaneous) (SCImago - 2012). Publicado • 10.1523/jneurosci.0234-12.2012 Autio, Henri; Castren, Eero; Davis, Sabrina; Diogenes, Maria J; Jeronimo-Santos, Andre; Karkkainen, Elisa; Karpova, Nina; et al. "Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice.". Neurobiology of aging 33 6 (2012): 1122.e23-39. https://doi.org/10.1016/j.neurobiolaging.2011.11.006 \| IF 2012 = 6.2; last 5-year = 5.2 (ISI) Citations: 90 (Google Scholar); 62 (Clarivate); 62 (Scopus) \| TOP 5% - Neurology (clinical) (SCImago - 2012). 10.1016/j.neurobiolaging.2011.11.006 Ribeiro Morais, Goreti; Vicente Miranda, Hugo; Santos, Isabel C.; Santos, Isabel; Outeiro, Tiago F.; Paulo, Antonio. "Synthesis and in vitro evaluation of fluorinated styryl benzazoles as amyloid-probes". Bioorganic & Medicinal Chemistry 19 24 (2011): 7698-7710. http://dx.doi.org/10.1016/j.bmc.2011.09.065 \| IF 2011 = 2.921; last 5-year = 3 (ISI) Citations: 33 (Google Scholar); 21 (Publons); 21 (Scopus) \| Q1, Organic Chemistry (SCImago - 2011). Publicado • 10.1016/j.bmc.2011.09.065 Vicente Miranda, Hugo; Outeiro, Tiago Fleming. "The sour side of neurodegenerative disorders: the effects of protein glycation". The Journal of Pathology 221 1 (2009): 13-25. http://dx.doi.org/10.1002/path.2682 \| IF 2010: 7.274; last 5-year: 6.941 (ISI) Citations: 179 (Google Scholar); 116 (Clarivate); 125 (Scopus) \| TOP 1%, Third Best Pathology and Forensic Medicine (SCImago - 2010). Publicado • 10.1002/path.2682 Miranda, Hugo Vicente; Ferreira, António E. N.; Quintas, Alexandre; Cordeiro, Carlos; Freire, Ana Ponces. "Measuring intracellular enzyme concentrations". Biochemistry and Molecular Biology Education 36 2 (2008): 135-138. http://dx.doi.org/10.1002/bmb.20166 \| IF 2008 - 0.635; last 5-year 0.707 (Clarivate) \| Citations: 5 (Google Scholar); 1 (Clarivate); 3 (Scopus) \| Q4, Biochemistry (SCImago - 2008). Publicado • 10.1002/bmb.20166 Gomes, Ricardo Anjos; Miranda, Hugo Vicente; Sousa Silva, Marta; Graça, Gonçalo; Coelho, Ana Varela; do Nascimento Ferreira, António Eduardo; Cordeiro, Carlos; Freire, Ana Ponces. "Protein glycation and methylglyoxal metabolism in yeast: finding peptide needles in protein haystacks". FEMS Yeast Research 8 1 (2008): 174-181. http://dx.doi.org/10.1111/j.1567-1364.2007.00337.x \| IF 2008 2.579, last 5-year 2.629 (clarivate) \| Citations 32 (Google Scholar) 20 (Clarivate); 22 (Scopus) \| Q1 applied Microbiology and Biotechnology (SCImago). Publicado • 10.1111/j.1567-1364.2007.00337.x Gomes, Ricardo A.; Miranda, Hugo Vicente; Silva, Marta Sousa; Graça, Gonçalo; Coelho, Ana V.; Ferreira, António E.; Cordeiro, Carlos; Freire, Ana Ponces. "Yeast protein glycation in vivo by methylglyoxal: Molecular modification of glycolytic enzymes and heat shock proteins". FEBS Journal 273 23 (2006): 5273-5287. http://dx.doi.org/10.1111/j.1742-4658.2006.05520.x \| IF 2006 3.033, last 5-year 4.068 (ISI) \| Citations: 96 (Google Scholar); 65 (Clarivate); 68 (Scopus) \| Q1, Biochemistry (SCImago - 2006). Publicado • 10.1111/j.1742-4658.2006.05520.x Vicente Miranda, Hugo; Ferreira, António E.N.; Cordeiro, Carlos; Freire, Ana Ponces. "Kinetic assay for measurement of enzyme concentration in situ". Analytical Biochemistry 354 1 (2006): 148-150. http://dx.doi.org/10.1016/j.ab.2005.09.002 \| IF 2006 ¿ 2.948; last 5-year ¿ 2.564 (ISI) Citations: 2 (1oogle Scholar), 2 (Clarivate), 1 (Scopus) \| Q2 iochemistry (SCImago - 2006). Publicado • 10.1016/j.ab.2005.09.002 Gomes, Ricardo A.; Sousa Silva, Marta; Vicente Miranda, Hugo; Ferreira, Antonio E. N.; Cordeiro, Carlos A. A.; Freire, Ana Ponces. "Protein glycation in Saccharomyces cerevisiae. Argpyrimidine formation and methylglyoxal catabolism.". FEBS Journal 272 17 (2005): 4521-4531. http://dx.doi.org/10.1111/j.1742-4658.2005.04872.x \| IF:4.1 (Clarivate). Q1 - Biochemistry (SCIMago) \| Citations: 65 (Google Scholar); 42 (Clarivate); 44 (Scopus) \| Q1 Biochemistry (SCImago - 2005). Publicado • 10.1111/j.1742-4658.2005.04872.x
Capítulo de livro	Hugo Vicente Miranda; Paula Moreira; Catarina Oliveira. Autor correspondente: Hugo Vicente Miranda. "Secrets of Insulin: From Diabetes to Neurodegenerative Diseases - Corresponding Author". In 100 years of Insulin. Portugal: Sociedade Portuguesa Diabetologia, 2023. No prelo Capucho, Adriana M.; Chegão, Ana; Martins, Fátima O.; Melo, Bernardete F.; Madeira, Natália; Sacramento, Joana F.; Fonseca, Rosalina; Vicente Miranda, Hugo; Conde, Silvia V. Autor correspondente: Vicente Miranda, Hugo. "Carotid Body Resection Prevents Short-Term Spatial Memory Decline in Prediabetic Rats Without Changing Insulin Signaling in the Hippocampus and Prefrontal Cortex - CORRESPONDING AUTHOR". In Arterial Chemoreceptors, editado por Conde, Silvia V. Springer - Advances in Experimental Medicine and Biology, 2023. No prelo Tenreiro, Sandra; Paulo Pereira; Vieira, Otília V; Guimas Almeida, Claudia; Vicente Miranda, Hugo; Helena Vieira; Miguel C Seabra. "Age-related diseases: common mechanisms and therapeutic approaches". In "Life Molecules to Global Health" - 150th anniversary Alfredo da Silva, editado por José Fragata. Principia, 2021. Publicado Susana Gonçalves* Co-first; Hugo Vicente Miranda* Co-first; Tiago F. Outeiro. "Novel Molecular Therapeutics in Parkinson's Disease". In Molecular and Cellular Therapeutics, editado por David Whitehouse; Ralph Rapley, 245-265. Wiley-Blackwell, 2012. 10.1002/9781119967309.ch11 Quintas, Alexandre; Oliveira, L. M. A.; Vicente Miranda, Hugo. "O sistema piruvato desidrogenase". In Bioquímica - organização molecular da vida, editado por Manuel Júdice Halpern; Ana Ponces Freire; Alexandre Quintas. Portugal: LIDEL edições técnicas Lda, 2008. Publicado
Poster em conferência	Sousa, Luis; Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. "Unveiling Insulin-degrading enzyme as a new therapeutic target for Parkinson's disease". Trabalho apresentado em FENS Regional Meeting 2023, 2023. Capucho, AM; Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. "Impact of carotid sinus nerve resection on cognitive function and synaptic plasticity in an animal model of dysmetabolism". Trabalho apresentado em FENS Regional Meeting 2023, 2023. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. "Glycation modulates glutamatergic signalling and exacerbates Parkinson's disease-like phenotypes". Trabalho apresentado em FENS Regional Meeting 2023, 2023. Capucho, Adriana M.; Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. "Carotid body modulation prevents cognitive deficits and regulates levels of neurodegenerative markers in dysmetabolic rats¿". Trabalho apresentado em Warsaw, Poland - 15th International Symposium "Molecular basis of pathology and therapy in neurological disorders", 2022. Capucho, Adriana M.; Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. "Carotid body modulation prevents cognitive dysfunction and neurodegenerative processes in prediabetic rats". Trabalho apresentado em Europhysiology 2022 - Copenhagen, 2022. Vicente Miranda, Hugo. "Glycation Modulates Glutamatergic Signaling and Exacerbates Parkinson’s Disease-Like Phenotypes". Trabalho apresentado em Synuclein Meeting 2022 - Leuven, Belgium, 2022. "Glycation modulates glutamatergic signalling and exacerbates Parkinson’s disease-like phenotypes". Trabalho apresentado em XVII Meeting of Portuguese Society for Neuroscience, 2021. "Mice overexpressing alpha-synuclein in the brain presente alterations in oxidative phosphorylation, endocytosis and synaptic vesicles dynamis in the midbrain". Trabalho apresentado em XVII Meeting of Portuguese Society for Neuroscience, 2021. "Unveiling insulin degrading enzyme as a new therapeutic target for Parkinson’s disease". Trabalho apresentado em XVII Meeting of Portuguese Society for Neuroscience, 2021. "Carotid sinus nerve resection prevents cognitive dysfunction in an animal model of dysmetabolism". Trabalho apresentado em SPN Meeting – Congress of Portuguese Neuroscience Society, 2021. "Glycation modulates glutamatergic signalling and exacerbates Parkinson’s disease-like phenotypes". Trabalho apresentado em European Physiology Day 2021, 2021. "Carotid sinus nerve resection prevents cognitive dysfunction in an animal model of dysmetabolism". Trabalho apresentado em European Physiology Day 2021, 2021. "Glycation induces Parkinson’s disease-like phenotypes in a mouse model of synucleinopathies via dysregulation of glutamatergic signaling and synaptic transmission - BEST POSTER PRIZE". Trabalho apresentado em ENCODS 2021 Virtual Meeting, 2021. Ana Chegão; Joana E Coelho; Inês Marques-Morgado; Mariana Guarda; Luísa V. Lopes; Tiago Fleming Outeiro; Vicente Miranda, Hugo. "Glycation impairs motor, cognitive and olfactory performance in a mouse model of synucleinopathy". Trabalho apresentado em FENS 2020 Virtual Forum, 2020. Sousa, Luís; Guarda, Mariana; de Oliveira, R. M.; Chegão, Ana; Sousa-Lima, I; Marçal, Ana Rita; Macedo, Maria Paula; Vicente Miranda, Hugo. "Mice under high-fat diet show reduced levels of insulin degrading enzyme and accumulation of alpha-synuclein in the brain". Trabalho apresentado em 16th Portuguese Congress of Diabetes, 2020. Guarda, Mariana; Chegão, Ana; Fernandes Gomes, Bárbara; de Oliveira, R. M.; Sousa, L.; Sousa-Lima, I.; Macedo, M. P.; Vicente Miranda, Hugo. "Unveiling insulin degrading enzyme as a novel therapeutic target for Parkinson’s disease". Trabalho apresentado em iMED conference, 2019. Chegão, Ana; Fernandes Gomes, Bárbara; Outeiro, Tiago Fleming; Vicente Miranda, Hugo. "Metformin prevents the deleterious effects of glycation in cellular models of synucleinopathies \| Corresponding Author". Trabalho apresentado em Synuclein Meeting 2019, 2019. Vicente Miranda, Hugo; Chegão, Ana; Oliveira, Márcia; Fernandes Gomes, Bárbara; Outeiro, Tiago Fleming. "Hsp27 prevents the deleterious effects of glycation in alpha-synuclein pathobiology \| Corresponding Author". Trabalho apresentado em Synuclein Meeting 2019, 2019. Gomes, Joana; Fonseca-Gomes, João; Vicente Miranda, Hugo; Sebastiao, A. M.; Diogenes, M. J.; Vaz, S. H.. "On the role of astrocytes upon Aß-mediated neurotoxicity". Trabalho apresentado em XIV European Meeting on Glial Cells in Health and Disease, 2019. Vicente Miranda, Hugo. "Development of a novel therapeutic strategy to prevent the loss of BDNF signaling in Alzheimer’s disease". Trabalho apresentado em The 14th international conference on Alzheimer's and Parkinson's diseases, 2019. Vicente Miranda, Hugo; Chegão, Ana; Oliveira, Márcia; Fernandes Gomes, Bárbara; Outeiro, Tiago Fleming. "Hsp27 prevents the deleterious effects of glycation in Parkinson’s disease models \| Corresponding author". Trabalho apresentado em The 14th international conference on Alzheimer's and Parkinson's diseases, 2019. Chegão, Ana; Fernandes Gomes, Bárbara; Outeiro, Tiago Fleming; Vicente Miranda, Hugo. "Metformin prevents the deleterious effects of glycation in cellular models of Parkinson’s disease. \| Corresponding author". Trabalho apresentado em The 14th international conference on Alzheimer's and Parkinson's diseases, 2019. Vicente Miranda, Hugo. "Metformin prevents the deleterious effects of glycation in cellular models of Parkinson’s disease. Workshop on integrative approaches in neurodegeneration.". Trabalho apresentado em FlySMALS consortium, Funded by European research projects for Cross-Disease Analysis of Pathways related to Neurodegenerative Diseases, 2018. Vicente Miranda, Hugo. "Metformin prevents the deleterious effects of glycation in cellular models of Parkinson’s disease.". Trabalho apresentado em 2nd NMS Symposium on Chronic Diseases and Translational Science, 2018. Vicente Miranda, Hugo. "a-synuclein posttranslational modifications as blood biomarkers for Parkinson's disease". Trabalho apresentado em ADPD, Mar 28 - Apr 3, Vienna, Austria., 2017. Vicente Miranda, Hugo. "PRPC mediates synaptic damage triggered by a-synuclein oligomers". Trabalho apresentado em ADPD, Mar 28 - Apr 3, Vienna, Austria., 2017. Vicente Miranda, Hugo. "Yeast uncover glycation as a modulator of a-synuclein-associated neurodegeneration". Trabalho apresentado em FENS, Jul 2-6, Copenhagen, Denmark., 2016. Vicente Miranda, Hugo. "Adenosine A2A receptors modulate alpha-synuclein toxicity and aggregation". Trabalho apresentado em Reunião da Sociedade Portuguesa de Farmacologia, Lisboa, Portugal, 2015. Vicente Miranda, Hugo. "Alpha-synuclein oligomers fail to induces synaptic dysfunction in adenosine A2A receptor knockout-mice". Trabalho apresentado em 9th FENS Forum of Neuroscience, Milan, Italy, 2014. Vicente Miranda, Hugo. "Glycation Modulates Huntingtin Aggregation and Toxicity". Trabalho apresentado em EHDN Plenary meeting, Barcelona, Spain., 2014. Vicente Miranda, Hugo. "Adenosine A2A receptor blockade prevents LTP impairment induced by a-synuclein". Trabalho apresentado em XIII Reunião da Sociedade Portuguesa de Neurociências (SPN), Luso, Portugal, 2013. Vicente Miranda, Hugo. "Heat-mediated enrichement of a-synuclein from cells and tissue for assessing post-translational modifications.". Trabalho apresentado em Portuguese Society for Neurosciences (SPN) meeting 2013, Luso, Portugal. May 30–June 1, 2013, 2013. Vicente Miranda, Hugo. "Adenosine A2A receptor blockade prevents LTP impairment induced by alpha-synuclein". Trabalho apresentado em XIII Reunião da Sociedade Portuguesa de Neurociências, Luso, Portugal. May 30–June 1, 2013, 2013. Vicente Miranda, Hugo. "Alpha-synuclein secretion: regulatory mechanisms and role in microglia activation and neurodegeneration in Parkinson’s disease". Trabalho apresentado em 8th FENS forum of Neuroscience, Barcelona July 14-18, Spain., 2012. Vicente Miranda, Hugo. "A method for rapid enrichment and characterization of post-translational modifications of the Parkinson’s associate protein alpha-synuclein,". Trabalho apresentado em I NeuroSeS Annual Symposium, Instituto de Medicina Molecular, Lisbon June 11, Portugal., 2011. Vicente Miranda, Hugo. "The role of alfa-synuclein secretion in microglia activation and neurodegeneration in Parkinson’s disease". Trabalho apresentado em XII Meeting Portuguese Society for Neurosciences, Instituto de Medicina Molecular, Lisbon May 26-28, Portugal. P-58., 2011. Vicente Miranda, Hugo. "SIRT2: Crossing the bridge between ageing and neurodegeneration". Trabalho apresentado em XII Meeting Portuguese Society for Neurosciences, Instituto de Medicina Molecular, Lisbon May 26-28, Portugal. P-17., 2011. Vicente Miranda, Hugo. "A method for rapid enrichment and characterization of post-translational modifications of the Parkinson’s associate protein alpha-synuclein". Trabalho apresentado em XII Meeting Portuguese Society for Neurosciences, Instituto de Medicina Molecular, Lisbon May 26-28, Portugal. P-4., 2011. Vicente Miranda, Hugo. "Yeast as a model to investigate the role and regulation of alpha-synuclein phosphorylation in Parkinson's disease.". Trabalho apresentado em The 24th International Conference on Yeast Genetics & Molecular Biology, Manchester, United Kingdom., 2009. Vicente Miranda, Hugo. "Parameter estimation in multi-enzyme systems using time-course analysis and in situ techniques". Trabalho apresentado em The 25th International Specialised Symposium on Yeasts, ISSY25, Finland., 2006. Vicente Miranda, Hugo. "MAGE in yeast: a cellular model of protein glycation in vivo.". Trabalho apresentado em The 25th International Specialised Symposium on Yeasts, ISSY25, Finland., 2006. Vicente Miranda, Hugo. "Advanced glycation end-products in yeast: formation and defence mechanisms". Trabalho apresentado em XIV Congresso Nacional de Bioquímica, Vilamoura - Portugal., 2004.
Recurso online	Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. World diabetes Day 2021. 2021. https://www.youtube.com/watch?v=whelUALDWQg. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. Social Media Day. 2021. https://www.youtube.com/watch?v=IszEhLuqlVk&t=1s. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. World Parkinson's disease Day 2021 - Documentary. 2021. https://www.youtube.com/watch?v=B8oeuXAz7gY. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. Hsp27 protection in Parkinson's disease. 2020. https://youtu.be/0Huf1fzIrOc. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. Ana Chegão was awarded an EMBO short-term fellowship. 2020. https://youtu.be/6gJnrdcEQsM. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. World Parkinson's day 2020 @DysBrainD. 2020. https://youtu.be/c0h6td_RnKc. Vicente Miranda, Hugo. World Diabetes Day 2019 - Youtube Video. 2019. https://www.youtube.com/watch?v=zI4HqCml4YI&t=88s. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. Dia Mundial da Diabetes 2019 - Youtube Video. 2019. https://www.youtube.com/watch?v=KTdui_QkmC0&t=59s. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. Biomarkers for Parkinson's Disease - Youtube Video. 2017. https://www.youtube.com/watch?v=T3PJKuMXD6s. Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. Biomarcadores para a doença de Parkinson - Youtube Video. 2017. https://www.youtube.com/watch?v=btAdfCPVi3M.
Tese / Dissertação	"Underlying role of glycation in the pathogenesis of Parkinson's disease - Ana Chegão Thesis Completed in December 2022". Doutoramento, Universidade Nova de Lisboa Faculdade de Ciências Médicas, 2022. "The role of carotid body in brain insulin resistance and Neurodegeneration - Adriana Capucho - Rank 20 out of 20!". Mestrado, Universidade Nova de Lisboa Faculdade de Ciências Médicas, 2022. "Role of SNARE-dependent Gliotransmitters Release in Alzheimer¿s Disease: from astrocytes to circuits - Daniela Abreu - Scored 19 out of 20". Mestrado, Universidade Nova de Lisboa Faculdade de Ciências Médicas, 2021. Vicente Miranda, Hugo. "Insulin-Degrading enzyme as a suppressor of alpha-synuclein pathogenesis - Ana Rita Marçal - Scored 19 out of 20". Mestrado, Universidade de Lisboa Faculdade de Ciências, 2021. SUPERVISOR. "Nanoparticle and liposome-based microreactors as reactive oxygen species scavengers in neuroinflammation 3D models - Oksana Savchak - Scored 19 out of 20". Mestrado, Universidade Nova de Lisboa Faculdade de Ciências Médicas, 2021. "Unveiling paracrine dissemination and toxicity of neuronal TrkB-ICD via secretome/exosome signaling in Alzheimer¿s Disease - Tiago Coelho - Scored 19 out of 20". Mestrado, Universidade Nova de Lisboa Faculdade de Ciências Médicas, 2021. Vicente Miranda, Hugo. "Insulin degrading enzyme as a therapeutic target for Parkinson¿s disease - Mariana Guarda - Scored 17 out of 20". Mestrado, Universidade Nova de Lisboa Faculdade de Ciências Médicas, 2019. SUPERVISOR. Miranda, Hugo Miguel Vicente,1982-; Caeiro, Filomena,1950-; Gomes, Bárbara Alexandra Fernandes. "Targeting the glycation defenses as a protective strategy for Parkinson's disease - Bárbara Fernandes Gomes - Scored 20 out of 20!!". Mestrado, 2017. http://hdl.handle.net/10451/30537. Vicente Miranda, Hugo. "Alpha-Synuclein as a blood biomarker for Parkinson¿s disease - Rafaela Cássio - Scored 19 out of 20". Mestrado, Instituto de Medicina Molecular, 2015. SUPERVISOR. Outeiro, Tiago; Miranda, Hugo; Oliveira, Márcia Santos. "Modulation of a-synuclein aggregation and toxicity - Márcia Oliveira - Scored 18 out of 20". Mestrado, Instituto de Medicina Molecular, 2013. http://hdl.handle.net/10362/11195 SUPERVISOR. Quintas, Alexandre; Miranda, Hugo Miguel Vicente, 1982-. "Protein glycation and methylglyoxal metabolism in Parkinson's disease - Hugo Vicente Miranda". Doutoramento, Fundação da Faculdade de Ciências da Universidade de Lisboa, 2010. http://catalogo.ul.pt/F/?func=item-global&doc_library=ULB01&type=03&doc_number=000572162. Vicente Miranda, Hugo. "Methylglyoxal metabolism and protein glycation in Saccharomyces cerevisiae - Hugo Vicente Miranda - Scored 20 out of 20!!". Licenciatura, Universidade de Lisboa Faculdade de Ciências, 2005.
Website	Vicente Miranda, Hugo. Autor correspondente: Vicente Miranda, Hugo. DysBrainD: Dysmetabolism in Brain diseases. 2018. https://nms.unl.pt/pt-pt/investigacao/grupos-de-investigacao/detalhe/n/dysbraind-dismetabolismo-em-doencas-do-cerebro.

Atividades

Apresentação oral de trabalho

	Título da apresentação	Nome do evento Anfitrião (Local do evento)
2023/06/07	The sour side of Diabetes: Is Parkinson's disease a brain comorbidity?	ESCI Annual Scientific Meeting European Society for Clinical Investigation (ESCI) (Prague, República Checa)
2022/12/07	Links between Diabetes and Parkinson's disease: myth or reality?	International Diabetes Federation World Congress International Diabetes Federation (IDF) (Lisbon, Portugal)
2022/10/26	Glycatome: an underlying link between sugars and Brain diseases	Aveiro IBIMED Seminers IBIMED (Aveiro, Portugal)
2022/10/22	Carotid body modulation prevents cognitive dysfunction and neurodegenerative processes in prediabetic rats - Adriana Capucho (MSc student)	15th International Symposium “Molecular basis of pathology and therapy in neurological disorders” (Warsaw, Polónia)
2022/03	Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes	International conference on Alzheimer's and Parkinson's Diseases and related neurological disorders (AD/PD), Barcelona, Spain Barcelona, Spain (Barcelona, Espanha)
2021/10/13	Brain glycation exacerbates Parkinson's disease-like phenotypes by dysregulating glutamatergic-related proteins in the midbrain - RISING STAR AWARD - Ana Chegão (PhD student)	3rd NMS Symposium on Chronic Diseases and Translational Science Virtual Meeting
2021/10/13	Carotid sinus nerve resection prevents cognitive dysfunction in an animal model of dysmetabolism - BEST 3 MINUTES FLASH TALK - Adriana Capucho (MSc student)	3rd NMS Symposium on Chronic Diseases and Translational Science Virtual Meeting
2021/10/12	Glycation modulates glutamatergic signalling and exacerbates Parkinson¿s disease-like phenotypes - BEST TALK PRIZE - Ana Chegão (PhD student)	European Physiology Day 2021 Virtual Meeting
2021/10/12	Carotid sinus nerve resection prevents cognitive dysfunction in an animal model of dysmetabolism - 2nd BEST TALK PRIZE - Adriana Capucho (MSc Student)	European Physiology Day 2021 Virtual Meeting
2021/05/17	Thinking head (Cabecinha Pensadora) [Invited Speaker]	Pint of Science Pint of Science - Lisbon, Portugal (Lisbon, Portugal)
2021/02/08	Zooming in on the effects of Diabetes in Parkinson’s disease neuropathology [Invited Speaker]	Neuroscience Seminar Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal)
2021	Where did your Postdoc take you? ¿ [Invited Speaker]	PostDoc Appreciation Week i3s and COLife
2020/05/06	Crosstalk between Diabetes and Parkinson's disease [Invited Speaker]	University of Leicester - Seminars Department of Genetics and Genome Biology, University of Leicester (Leicester, Reino Unido)
2020/03/06	Brain glycation potentiates motor, cognitive and olfactive dysfunction in mice overexpressing alpha-synuclein	Portuguese Congress of Diabetes Sociedade Portuguesa de Diabetologia (Vilamoura, Portugal)
2020/03/06	Regulation of insulin degrading enzyme has therapeutic potential in a cellular model of Parkinson's disease	16th Portuguese Congress of diabetes Sociedade Portuguesa de Diabetologia (Vilamoura, Portugal)
2020/02/13	Round Table - Studying abroad [Invited Speaker]	2nd Meeting of Biochemistry MSc programme Faculdade de Ciências - Universidade de Lisboa (Lisboa, Portugal)
2019/10/30	Papel da Investigação laboratorial no desenvolvimento de novas terapias "Role of laboratory research in the development of new therapies" [Invited Speaker]	AIMS Masterclass - Changing the World and Medicine Faculdade de Medicina, Universidade de Lisboa (Lisboa, Portugal)
2019/10/11	Lessons From Diabetes: Novel Parkinson's disease causative factors [Invited Speaker]	Friedrich-Alexender Universitat Erlangen-Nürnberg, Universitätsklinikum Erlangen - Lectures For!nter - BAVARIAN RESEARCH ASSOCIATION INTERACTION OF HUMAN BRAIN CELLS (Erlangen, Alemanha)
2019/04/11	Unveiling therapeutic solutions for Parkinson's disease [Invited Speaker]	World day of Parkinson's disease Portuguese Association of Parkinson's disease (Lisboa, Portugal)
2019/03/08	Anti-glycation drugs as therapeutic strategy for Parkinson's disease [Selected Speaker]	15º Congresso da Sociedade Portuguesa de Diabetologia Tivoli Marina Hotel (Vilamoura, Portugal)
2018/10/18	Metformin prevents the deleterious effects of glycation in cellular models of Parkinson's disease	NOVA Medical School Symposium Universidade Nova de Lisboa, Faculdade de Ciências Médicas (Lisboa, Portugal)
2018	Effects of protein glycation in neurodegenerative diseases. [Invited Speaker]	3rd BioSAM – Biological Sciences Annual Meeting Faculty of Sciences of the university of Lisbon, Portugal (Lisbon, Portugal)
2017	Sour side of sugars: Glycation in Huntington’s disease [Invited Speaker]	Jornadas Lusófonas de Nutrição Universidade Lusófona (Lisboa, Portugal)
2015/03	Glycation disrupts proteostasis and promotes neurodegenerative alterations in synucleinopathies	12th Alzheimer’s Disease and Parkinson Disease congress Alzheimer’s Disease and Parkinson Disease (Nice, França)
2015	Adenosine A2A receptors as potential targets for Parkinson's disease-related cognitive deficits	Sociedade Portuguesa de Neurociências Sociedade Portuguesa de Neurociências (Ofir, Portugal)
2015	Alpha-synuclein as a blood biomarker for Parkinson’s disease [Selected Speaker]	Reunião da Sociedade Portuguesa das doenças do Movimento Sociedade Portuguesa das doenças do Movimento (Ofir, Portugal)
2014/11	Glycation disrupts proteostasis and promotes neurodegenerative alterations in synucleinopathies	Society for Neurosciences (SFN) Society for Neurosciences (SFN) (Washington, Estados Unidos)
2014	AGE in yeast? New insights into the role of AGE and RAGE in health and disease	EASD Symposia (Munich, Alemanha)
2014	Alpha-synuclein as a blood biomarker for Parkinson’s disease [Selected Speaker]	Reunião da Sociedade Portuguesa das doenças do Movimento Sociedade Portuguesa das doenças do Movimento (Vimeiro, Portugal)
2013	Adenosine A2A receptor - A putative player in alpha-synuclein induced LTP impairment	Society for Neuroscience (SFN) Annual Meeting Society for Neuroscience (SFN) (California, Estados Unidos)
2013	Heat-mediated enrichement of a-synuclein from cells and tissue for assessing post-translational modifications. [Selected Speaker]	Reunião da Sociedade Portuguesa das doenças do Movimento Sociedade Portuguesa das doenças do Movimento (Vimeiro, Portugal)
2013	Deciphering the molecular effects of alpha-synuclein post-translational modifications. [Invited Speaker]	7th Framework Programme for RTD - Grant Agreement HEALTH-2009-241791, MEFOPA MEFOPA (Roma)
2013	Adenosine A2A receptor blockade prevents LTP impairment induced by alpha-synuclein	XIII Reunião da Sociedade Portuguesa de Neurociências Sociedade Portuguesa de Neurociências (Luso, Portugal)
2010	Protein Glycation in Yeast: Novel Insights into the molecular basis of Parkinson's Disease.	Lisbon Area Neuroscience Meeting Instituto Gulbenkian Ciência (Oeiras, Portugal)
2010	The effects of glycation on alpha-synuclein misfolding and toxicity in a yeast model of Parkinson’s disease	XIII Jornadas de biologia de leveduras “Nicolau van Uden” (Lisboa, Portugal)
2009	Protein glycation and methylglyoxal metabolism in Parkinson’s disease	IMM PhD students Meeting Instituto de Medicina Molecular (Lisboa, Portugal)
2008	Protein glycation and methylglyoxal metabolism in Parkinson’s disease	IMM PhD students Meeting Instituto de Medicina Molecular (Lisboa, Portugal)
2005	Parameter estimation in multi-enzyme systems using evolutionary algorithms	BKDB2005 - Bioinformatics: Knowledge Discovery in Biology (Lisboa, Portugal)

Orientação

	Título / Tema Papel desempenhado	Curso (Tipo) Instituição / Organização
2023/01 - 2026/12	The therapeutic role of carotid body modulation in animal models of dysmetabolism-induced neurodegeneration and of Parkinson’s disease Orientador	Biomedicina (Doutoramento) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/09 - 2024/02/29	Unveiling insulin degrading enzyme as a therapeutic target for Parkinson’s disease - Luís Sousa Orientador	PhD in Health Sciences (Doutoramento) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021 - 2024	Role of IL-10 in Long-Covid - José Feliz Orientador	Medicine (Doutoramento) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2022/09 - 2023/08	Therapeutic potential of anti-glycation compounds in animal models of Parkinson's disease Orientador	Biologia Molecular e Genética (Mestrado) Universidade de Lisboa Faculdade de Ciências, Portugal
2018/03/01 - 2022/04/01	Underlying role of glycation in the pathogenesis of Parkinson's disease - Ana Chegão - Thesis delivery in April 2022 Orientador de Ana Chegão	Regenerative Medicine and Mechanisms of Disease (Doutoramento) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/09 - 2022/02/25	The role of carotid body in brain insulin resistance and Neurodegeneration - Adriana Capucho - Ranked 20 out of 20! Orientador de Adriana Capucho	Investigação Biomédica (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020 - 2021	Role of SNARE-dependent Gliotransmitters Release in Alzheimer's Disease: from astrocytes to circuits - Daniela Abreu - Ranked 19 out of 20! Coorientador de Daniela Abreu	Investigação Biomédica (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020 - 2021	Nanoparticle and liposome-based microreactors as reactive oxygen species scavengers in neuroinflammation 3D models - Oksana Savchak - Ranked 19 out of 20! Coorientador de Oksana Savchak	Bioquímica para a Saúde (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2020 - 2021	Unveiling paracrine dissemination and toxicity of neuronal TrkB-ICD via secretome/exosome signaling in Alzheimer's Disease - Tiago Coelho - Ranked 19 out of 20 Coorientador	Bioquímica para a Saúde (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2019/09/01 - 2020/08/31	Insulin Degrading Enzyme as a suppressor of alpha-synuclein pathogenesis - Ana Rita Marçal - Ranked 19 out of 20 Orientador	MSc in Medical Biochemistry (Mestrado) Universidade de Lisboa Faculdade de Ciências, Portugal
2020/02 - 2020/03	Exploring the protection mechanism of insulin degrading enzyme over alpha-synuclein pathology in a cellular model of Parkinson's disease - Adriana Capucho Orientador	Biomedical Research - Laboratory Rotation (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/01 - 2020/02	Impact of brain glycation in a mouse model of Parkinson's disease - Erik Cardoso Orientador	Biomedical Research - Laboratory Rotation (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2018/09 - 2019/12/09	Insulin degrading enzyme as a therapeutic target for Parkinson's disease - Mariana Guarda - Ranked 17 out of 20 Orientador de Mariana Guarda	Mestrado NOVA Biomedical Research (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/09/01 - 2019/09/30	Impact of Insulin Degrading Enzyme on alpha-synuclein properties (solubility, toxicity, protein levels) - Yanni Schneider Orientador	Molecular Medicine - International internship (Mestrado) Friedrich-Alexander-Universität Erlangen-Nürnberg Medizinische Fakultät, Alemanha
2018 - 2019/07	Sugar stress in the Brain - Bárbara Fernandes Gomes Orientador de Bárbara Fernandes Gomes	Projecto de Investigação (Outra) Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal
2019/04 - 2019/05	Sugar stress in the Brain: targeting glycation as a novel therapeutic avenue for Parkinson's disease - Paloma Domingos Orientador	Medicine - Research Project (Licenciatura/Bacharelato) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/04 - 2019/05	Glycation role in alpha-synuclein-associated Neurodegeneration: developing a mouse model to assess the neuropathological and behaviour effects of glycation - Miguel Mesquita Orientador	Biomedical Research - Laboratory rotation (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/01 - 2019/04	Sugar Stress In The Brain: The Missing Link Between Diabetes and Parkinson’s Disease - Diana Chamiço Orientador de Diana Chamiço	Biologia Celular e Molecular (Licenciatura/Bacharelato) Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2019/02/04 - 2019/03/15	The effects of brain protein glycation in a mouse model of Parkinson's disease - Ana Pinto Orientador	Biomedical Research - Laboratory Rotation (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2016 - 2018	Targeting the glycation defences as a protective strategy for Parkinson's Disease - Ana Chegão Orientador de Ana Chegão	Project de Investigação (Outra) Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal
2016 - 2017	Targeting the glycation defences as a protective strategy for Parkinson's Disease - Bárbara Fernandes Gomes - Scored 20 out of 20!! Orientador de Bárbara Fernandes Gomes	Mestrado em Biologia molecular e celular (Mestrado) Universidade Nova de Lisboa Centro de Estudos de Doenças Crónicas, Portugal
2013 - 2015	Alpha-synuclein as a blood biomarker for Parkinson's Disease - Rafaela Cássio - Scored 19 out of 20! Orientador de Rafaela Cássio	Mestrado em Neurociências (Mestrado) Faculdade de Medicina da Universidade de Lisboa, Portugal
2014 - 2014	Alpha-synuclein as a blood biomarker for Parkinson's Disease - Márcia Oliveira Orientador de Márcia Oliveira	Projecto de Investigação (Outra) Instituto de Medicina Molecular, Portugal
2013 - 2014	Alpha-synuclein as a blood biomarker for Parkinson's Disease - Marcos António Gomes Orientador de Marcos António Gomes	Projecto de Investigação (Outra) Instituto de Medicina Molecular, Portugal
2012 - 2013	Modulation of alpha-synuclein aggregation and toxicity - Márcia Oliveira - Scored 18 out of 20 Orientador de Márcia Oliveira	Mestrado em Genética Molecular e Biomedicina (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal

Organização de evento

	Nome do evento Tipo de evento (Tipo de participação)	Instituição / Organização
2020/09 - 2021/08	Organiser and moderator of Principal Investigators Weekly Chalk-Talks (2020/09 - 2021/08) Seminário (Presidente da Comissão Organizadora)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/09 - 2021/08	Organiser and Moderator of Principal Investigator Monthly Meetings (2020/09 - 2021/08) Encontro (Presidente da Comissão Organizadora)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/02/01 - 2021/01/31	Journal Club of Neurosciences (2020/02/01 - 2021/01/31) Seminário (Presidente da Comissão Organizadora)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2015 - 2016	Organizer of Pizza Seminars (2015 - 2016) Seminário (Coorganizador)	Instituto de Medicina Molecular, Portugal
2015 - 2015	2nd inter-institutional post-doc retreat (2015 - 2015) Congresso (Coorganizador)	Instituto de Medicina Molecular, Portugal Instituto Gulbenkian de Ciência, Portugal Instituto de Biologia Experimental e Tecnológica, Portugal Fundação Champalimaud, Portugal
2015 - 2015	Organizer of Career Path Seminars (2015 - 2015) Seminário (Coorganizador)	Instituto de Medicina Molecular, Portugal
2011 - 2011	Brain awareness week: Parkinsonic Yeast (2011 - 2011) Oficina (workshop) (Coorganizador)	Instituto de Medicina Molecular, Portugal

Participação em evento

	Descrição da atividade Tipo de evento	Nome do evento Instituição / Organização
2021/03/11 - 2021/03/17	Chair/Moderator - Portuguese Congress of Diabetes - Fundamental Research Congresso	17º Congresso de Diabetes Sociedade Portuguesa de Diabetologia, Portugal
2020/02/13 - 2020/02/13	2º Encontro do Mestrado em Bioquímica – 2020 - Round table speaker Mesa-redonda	Sessão V – A Bioquímica em perspetiva (Biochemistry in Perspective) Universidade de Lisboa Faculdade de Ciências, Portugal
2017 - 2017	Chair VI annual CEDOC PhDOC Meeting Encontro	VI annual CEDOC PhDOC Meeting Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2014 - 2014	Chair of CAML PhD Student's meeting Encontro	Universidade de Lisboa Faculdade de Medicina, Portugal

Júri de grau académico

	Tema Tipo de participação	Nome do candidato (Tipo de grau) Instituição / Organização
2022/12	Underlying role of glycation in the pathogenesis of Parkinson's disease - Ana Chegão Thesis Completed in December 2022 Orientador	Ana Chegão (Doutoramento) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2022/11/25	THERAPEUTIC POTENTIAL OF INTRATHECAL APPLICATION OF miR-124-BASED SECRETOME IN THE SOD1G93A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS Arguente principal	Marta Alexandra Marques dos Santos (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2022/07	Studying the neuroprotective role of bone marrow-derived mesenchymal stem cell secretome using in vitro and in vivo models of Parkinson's disease Arguente principal	Bárbara Pinheiro (Doutoramento) Laboratório Associado ICVS 3B's, Portugal Universidade do Minho Escola de Medicina, Portugal
2021/12/16	The impact of the genetic risk factor BIN1 to Alzheimer’s disease development Arguente	Catarina Benavente Perdigão (Doutoramento) Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
2021/10/07	Targeting Neuroinflammation And Neurodegeneration In Parkinson’s Disease Arguente principal	Sara Oliveira (Doutoramento) Universidade de Lisboa Faculdade de Farmácia, Portugal
2021/02/03	Insulin-Degrading enzyme as a suppressor of alpha-synuclein pathogenesis Orientador	Ana Rita Miranda Marçal (Mestrado) Universidade de Lisboa Faculdade de Ciências, Portugal
2021/01/28	Effects of glycation by methylglyoxal in saccharomyces cerevisiae Arguente principal	Ana Sofia Mena Aires Pendão (Mestrado) Universidade de Lisboa Faculdade de Ciências, Portugal
2019/12/09	Insulin degrading enzyme as a therapeutic target for Parkinson¿s disease - Mariana Guarda Orientador	Mariana Guarda (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/11/22	Small molecule PGC-1a activators: A novel class of anti-neurodegenerative therapeutics Arguente principal	Catarina Isabel Ambrósio Ranito (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2019/10/24	Understanding the impact of sporadic Alzheimer’s disease mutations on BIN1 Arguente principal	Mariana Barata (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2017	Dissecting the effect of Parkinson's Disease related PINK1 mutations on kinase activity. Arguente principal	Filipa Alexandra Barroso Gonçalves (Mestrado) Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2017	Targeting the glycation defenses as a protective strategy for Parkinson's disease Orientador	Bárbara Gomes (Mestrado) Universidade de Lisboa Faculdade de Ciências, Portugal
2015/07/29	Alpha-Synuclein as a blood biomarker for Parkinson¿s disease Orientador	Rafaela Cássio (Mestrado) Instituto de Medicina Molecular, Portugal
2014	Selection of small domain antibodies specific for ß-Amyloid peptide Arguente principal	Pedro Canhão (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal

Arbitragem científica em conferência

	Nome da conferência	Local da conferência
2021/06/16 - 2021/06/18	Third CEDOC Symposium on Chronic Diseases and Translational Science	Nova Medical School

Arbitragem científica em revista

	Nome da revista (ISSN)	Editora
2022 - Atual	npj Parkinson's disease (2373-8057)	Nature
2021 - Atual	JOVE - Journal of visualised experiments (1940-087X)
2020 - Atual	Frontiers in Cell and Developmental Biology (2296-634X)	Frontiers
2020 - Atual	Biomolecules (2218-273X)	MDPI
2020 - Atual	Life (2075-1729)	MDPI
2020 - Atual	International Journal of Molecular Sciences (1422-0067)	MDPI
2017 - Atual	Frontiers in Neuroscience (1662-453X)	Frontiers
2017 - Atual	Canadian Journal of Physiology and Pharmacology (0008-4212)	Canadian Science Publishing

Comissão de avaliação

	Descrição da atividade Tipo de assessoria	Instituição / Organização	Entidade financiadora
2023/04 - Atual	Project Peer Reviewer Avaliador	EMSTAR Pratiksha Trust, Índia	EMSTAR Pratiksha Trust
2021 - Atual	Project Peer Reviewer Avaliador	Science Fund of the Republic of Serbia, Sérvia
2021 - Atual	Project Peer Reviewer Avaliador	Fondation Recherche Alzheimer, Bélgica	Fondation Recherche Alzheimer
2021 - Atual	Project Peer Reviewer Avaliador	Governo dos Açores, Portugal	Governo dos Açores
2021/03/18 - 2021/03/21	Research Competition Jury - Neurosciences Avaliador	AIMS Meeting 2021, Portugal
2021/03/11 - 2021/03/17	Oral Presentation Prize Jury Avaliador	Sociedade Portuguesa de Diabetologia, Portugal
2021/02/14 - 2021/03/06	Jury of Poster Sessions - International AIMS Meeting 2021 Avaliador	AIMS Meeting 2021, Portugal
2020/03/06 - 2020/03/08	Jury of Oral presentation awards Avaliador	Sociedade Portuguesa de Diabetologia, Portugal
2019/03/08 - 2019/03/10	Jury of Poster awards Avaliador	Sociedade Portuguesa de Diabetologia, Portugal	Sociedade Portuguesa de Diabetologia

Curso / Disciplina lecionado

	Disciplina	Curso (Tipo)	Instituição / Organização
2022/02 - Atual	Role of Glycation in diseases - Integration of Metabolism and Nutrition	Nutrição Humana e Metabolismo (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/10/21 - Atual	Post-translational Modifications Case Study: Neurodegenerative diseases	Bioquímica (Mestrado)	Universidade de Lisboa Faculdade de Ciências, Portugal
2022/09 - 2033/01	Cell and Molecular Biology	Medicina (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2023/01 - 2023/02	Project Development in Biomedicine	Biomedicine (Doutoramento)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2022/11/28 - 2022/12/13	Cell and Molecular Mechanisms of Aging and Associated Diseases - 35h	Cell and Molecular Mechanisms of Aging and Associated Diseases (Doktor (PhD))	EIT Health Ageing PhD School, Alemanha
2022/10/22 - 2022/10/22	Invited Lecture - Type-2 Diabetes and Parkinson's disease	Doenças Metabólicas e Comportamento Alimentar (Mestrado integrado)	Universidade de Lisboa Faculdade de Medicina, Portugal
2022/04 - 2022/04	How to evaluate neuronal loss in animal models of Neurodegeneration	Biomedical Research (Mestrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2022/01 - 2022/02	Project Development in Biomedicine	Biomedicine (Doutoramento)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2022/01 - 2022/01	Integrative Biomedicine	Biomedicina (Doutoramento)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021/12 - 2021/12	Invited lecture: Type 2 diabetes mellitus and its association with Parkinson’s disease and other neurodegenerative diseases	Doenças Metabólicas e Comportamento Alimentar (Mestrado integrado)	Universidade de Lisboa Faculdade de Medicina, Portugal
2021/11 - 2021/12	Cellular Regulation	Investigação Biomédica (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021/11 - 2021/11	Critical Skills	Biomedicina (Doutoramento)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021/10 - 2021/10	Critical Skills	Investigação Biomédica (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021/04 - 2021/04	How to evaluate neuronal loss in animal models of Neurodegeneration	Biomedical Research (Mestrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021/02/20 - 2021/02/20	Role of Glycation in diseases - Integration of Metabolism and Nutrition	Nutrição Humana e Metabolismo (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021/01 - 2021/02	Project Development in Biomedicine	PhD in Biomedicine (Curso de doutoramento (conclusão de unidades curriculares))	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/11 - 2020/12	Cellular Regulation	Investigação Biomédica (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/04/08 - 2020/04/08	How to evaluate neuronal loss in animal models of Neurodegeneration	Biomedical Research (Mestrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/02/08 - 2020/02/08	Role of Glycation in diseases - Integration of Metabolism and Nutrition	Nutrição Humana e Metabolismo (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020/02/03 - 2020/02/07	Medicina Translacional (Translational Medicine)	PhD in Mechanisms of Disease and Regenerative Medicine (Curso de doutoramento (conclusão de unidades curriculares))	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/11/29 - 2019/12/18	Cellular Regulation	Investigação Biomédica (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/11/13 - 2019/11/13	Post-translational Modifications Case Study: Neurodegenerative diseases	Bioquímica (Mestrado integrado)	Universidade de Lisboa Faculdade de Ciências, Portugal
2019/04/02 - 2019/04/02	How to evaluate neuronal loss in animal models of Neurodegeneration	Nova Biomedical Research MSc (Mestrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/02/15 - 2019/02/15	Evaluator on Translational Medicine (MSc Course)	NOVA Biomedical Research MSc Course (Curso de mestrado (conclusão do curso de especialização))	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/02/14 - 2019/02/14	Focus on Parkinson's Disease, Lecturer and Evaluator (MSc course)	NOVA Biomedical Research, MSc course (Curso de mestrado (conclusão do curso de especialização))	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/02/04 - 2019/02/08	Translational Medicine, Tutor and Evaluator (PhD course)	Biomedicine PhD Course (Curso de doutoramento (conclusão de unidades curriculares))	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/02/04 - 2019/02/08	Medicina Translacional (Translational Medicine)	PhD in Biomedicine (Curso de doutoramento (conclusão de unidades curriculares))	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2018 - 2019	Mecanismos Moleculares de Doença	Medicina (Mestrado integrado)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2017 - 2017	Molecular Basis of Biomedicine A Base Molecular da Biomedicina	Biomedicina (Doutoramento)	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal Universidade de Aveiro Departamento de Ciências Médicas, Portugal
2013 - 2013	High throughput techniques for proteomic characterization	CAML Ph.D. program (Doutoramento)	Instituto de Medicina Molecular, Portugal
2009 - 2009	Enzymology	Bioquímica (Licenciatura)	Universidade de Lisboa Faculdade de Ciências, Portugal
2009 - 2009	Bioquímica I	Ciências Forenses e Criminais (Licenciatura)	Instituto Superior de Ciências da Saúde Egas Moniz, Portugal
2005 - 2006	Bioquímica	Bioquímica (Licenciatura)	Universidade de Lisboa Faculdade de Ciências, Portugal
2005 - 2006	Enzymologia	Bioquímica (Doutoramento)	Universidade de Lisboa Faculdade de Ciências, Portugal
2005 - 2006	Bioquímica I	Ciências Farmacêuticas (Mestrado integrado)	Instituto Superior de Ciências da Saúde Egas Moniz, Portugal
2005 - 2005	High Performance Liquid chromatography Mass spectrometry theoretic and practical seminar to the Environmental and biological mass spectrometry group from Chemistry and Biochemistry Center from Faculdade de Ciências da Universidade de Lisboa.	(Especialização pós-licenciatura)	Universidade de Lisboa Faculdade de Ciências, Portugal
2004 - 2005	Bioquímica Experimental IV	Bioquímica (Licenciatura)	Universidade de Lisboa Faculdade de Ciências, Portugal
2004 - 2005	Simulação Computacional em Bioquímica Teóricas e Práticas	Bioquímica (Licenciatura)	Universidade de Lisboa Faculdade de Ciências, Portugal

Entrevista (jornal / revista)

	Descrição da atividade	Jornal / Forum
2022/12/06	Association between Diabetes and Parkinson's. Michael J. Fox Foundation funds NOVA Researchers A relação entre diabetes e Parkinson. Fundação Michael J. Fox financia cientistas da Nova	Diário de Notícias
2022/04/25	Type-2 Diabetes patients are at higher risk of developing Parkinson's disease Pessoas com diabetes de tipo 2 são mais propensas à doença de Parkinson	Público
2021/11/11	"Research project about the association between Parkinson's disease and diabetes awarded" Projecto de Investigação sobre relação entre doença de Parkinson e diabetes premiado	LUSA - Clipping in several national news platforms: SIC Noticias, Visão, Observador, Notícias ao Minuto, Sapo, Postal do Algarve, Jornal Médico, O Mirante, Saúde Online, BeiraNews, Impala, JM Madeira; Mundo actual; Notícias de Coímbra; Radio Regional...
2021/07/01	How do you communicate about the use of animals in Research	European Animal Research Association
2020/04/26	Title: A new relationship between diabetes and Parkinson's disease has been unveiled Portuguese scientists have been exploring the relationship between these diseases. They now bring us news about a protein that may contribute for a novel therapeutic strategy. This interview covered the latest publication about Hsp27 role in Parkinson's disease. Vicente Miranda, FASEB J, 2020	Jornal o Público
2020/04/26	"Finding another piece of the intricate relationship between diabetes and Parkinson's disease" Desvendada mais uma peça da relação intrincada entre a diabetes e a doença de Parkinson	Jornal O Público
2019/04/11	Relationship between Diabetes and Parkinson's disease? Portuguese researches explain	TSF radio notícias
2018/10/16	FCT does not have a deadline to present the reevaluation results of Scientific Research Projects "FCT não tem prazo para apresentar a reavaliação da candidatura dos projetos de investigação"	Observador
2018/07/06	If there is more funding in Science, why are the researchers unhappy? "Se há mais dinheiro na Ciência porque é que os investigadores estão descontentes?"	Observador
2018/05/23	About the unique call for FCT 2017 research projects "Sobre o concurso singular dos projetos FCT de 2017"	Observador
2018/04/11	Portuguese researchers found a way to detect Parkinson's disease in a blood analysis "Portugueses descobrem como detetar Parkinson com análise ao sangue"	Expresso
2017/11/27	Parkinson's disease leave scars in a protein in the blood "Doença de Parkinson deixa marcas numa proteína no sangue"	Jornal O Público

Entrevista / Programa (rádio / tv)

	Programa	Tema
2022/04/25 - 2022/04/25	TV News of Public Network RTP: People with Type II diabetes more likely to have Parkinson's	Parkinson's Disease
2021/05/24 - 2021/05/24	The life of a scientist podcast	The life of a Young PI
2021/02/18 - 2021/02/18	90 segundos de Ciência	Studying the impact of Diabetes in Parkinson's disease (Estudando o impacto da Diabetes na Doença de Parkinson)
2019/04/11 - 2019/04/11	Morning news - TSF	World Parkinson's disease day - Novel discoveries by DysBrainD
2017/04/11 - 2017/04/11	Diário da Manhã da TVI Interview provided by Tiago Outeiro, talking about my published work in PLOS Biology and Brain in 2017.	New hope for Parkinson's disease Patients / Há uma nova esperança para os doentes de Parkinson

Membro de associação

	Nome da associação	Tipo de participação
2021/03/07 - Atual	European Society for Neurochemistry	Member #1472
2021/03 - Atual	International Society for Neurochemistry	Member
2021/03 - Atual	FENS - Federation of European Neuroscience Societies	Member ESN28216
2018 - Atual	Sociedade Portuguesa Diabetologia	Member
2018 - Atual	Portuguese Society for Neurosciences	Member
2013 - Atual	Sociedade Portuguesa de Doenças do Movimento	Member
2013 - Atual	Movement Disorders Society	Member
2004 - Atual	Portuguese Biochemical Society	Member
2014 - 2016	IMM Postdoctoral association (PDA)	Elected Member of the committee

Membro de comissão

	Descrição da atividade Tipo de participação	Instituição / Organização
2020/02/01 - 2023/01/31	Elected representative of users of the cell culture Facility. Member of Decision panel of rules and strategy of cell culture facility in CEDOC, NOVA Medical School Membro	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2014 - 2016	Elected member of the direction of iMM Postdoctoral Association Diretor	Instituto de Medicina Molecular, Portugal

Outro júri / avaliação

	Descrição da atividade	Instituição / Organização
2019/03/01 - Atual	PhD Thesis Committee - Tatiana Burrinha - Lysosomes dysfunction, the link between Aging and Alzheimer ´s disease?	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/02/01 - Atual	PhD Thesis Committee - Diego Borges - New insights in insulin clearance	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2021 - 2025	PhD Thesis Committee - Mariana Afonso Barata - Breaking BIN1: Investigating mechanisms of synaptic dysfunction in Alzheimer’s disease	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2020 - 2024	PhD Thesis Committee - Bernardo Antunes - The Metabolic Profile of Brain Mitochondria	Instituto de Medicina Molecular, Portugal
2020 - 2024	PhD Thesis Committee - André Gabriel - Unraveling the functional interactions between circular RNAs and RNA binding proteins in atrial fibrillation	Instituto de Medicina Molecular, Portugal
2018 - 2022	PhD Thesis Committee - Filipa Gonçalves - Parkinson’s Disease and Mitochondrial dysfunction: the role of PINK1 in mitochondria maintenance and clearance	Instituto de Medicina Molecular, Portugal
2019/03/08 - 2019/03/10	Jury of Poster prize of Congresso da Sociedade Portuguesa de Diabetologia	Sociedade Portuguesa de Diabetologia, Portugal
2018 - 2018	Jury of PhD Thesis Committee - Sara Oliveira	Universidade de Lisboa Faculdade de Farmácia, Portugal
2018 - 2018	Jury of Poster Prize CEDOC PhD students retreat	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2018 - 2018	Jury of Poster Prize - CEDOC PhDOC Meeting	Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2013 - 2018	PhD Thesis Committee - Joana Branco dos Santos	Instituto de Medicina Molecular, Portugal

Tutoria

	Tópico	Nome do aluno
2012 - 2014	Deciphering the molecular role of DJ-1 in the etiology of Parkinson’s and Huntingtons’s disease	Leonor Fleming
2012 - 2014	The role of alpha-synuclein phosphorylation in synucleinopathies	Elisa Basso

Distinções

Prémio

2023	Award for Best Paper in Diabetology Sociedade Portuguesa de Diabetologia, Portugal
2021	Big Prize from Portuguese Diabetology Society Sociedade Portuguesa de Diabetologia, Portugal
2014	Award for best Poster at 8th EHDN Plenary meeting (Barcelona) European Huntington's Disease Network (EHDN), Espanha
2009	Award for best oral presentation Instituto de Medicina Molecular, Portugal

Outra distinção

2021	Research Grant: IDE as a biomarker. Vicente Miranda (PI) EUR 5.000,00 Sociedade Portuguesa de Diabetologia, Portugal
2021	Research Grant: Preventing the development of Parkinson's disease in Type-2 diabetes Patients. Vicente Miranda (PI) EUR 20.000,00 Sociedade Portuguesa de Diabetologia, Portugal
2021	Cover of Journal of Pathology Dec 2021 The Journal of Pathology, Reino Unido
2019	Junior Researcher [Awardee EUR 228.000,00] Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2018	Research Grant Sweet_PD_Multi/04462. Vicente Miranda (PI) EUR 70.000,00 iNOVA4Health, Portugal
2018	Research Grant: Stress dos Açucares no Cérebro. Vicente Miranda (PI) EUR 5.000,00 Sociedade Portuguesa de Diabetologia, Portugal
2017	HIGHLIGHT in Nature Reviews Molecular Cell Biology of "The mechanism of Sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson's disease", published in PLoS Biology Nature Reviews Molecular Cell Biology, Reino Unido
2016	Research Grant PTDC/NEU-OSD/5644/2014. Vicente Miranda (PI) EUR 199.961,00 Fundação para a Ciência e a Tecnologia, Portugal
2015	Post-doctoral Research Fellowship [Awardee EUR 118.000,00] Fundação para a Ciência e a Tecnologia, Portugal
2013	Research Grant: EXPL/NEU-OSD/0606/2012. Vicente Miranda (PI) (EUR 50.000,00) Fundação para a Ciência e a Tecnologia, Portugal
2012	Post-doctoral Research Fellowship [Awardee EUR 21.500,00] European Commission Seventh Framework Programme for Research and Technological Development, Bélgica
2010	Post-doctoral Research Fellowship [Awardee EUR 115.000,00] Fundação para a Ciência e a Tecnologia, Portugal
2006	PhD Fellowship [Awardee EUR 115.000,00] Fundação para a Ciência e a Tecnologia, Portugal